Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $151,600 | 15 | 87.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,400 | 4 | 12.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $79,000 | 6 | $0 (2024) |
| Glaukos Corporation | $62,600 | 7 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $22,400 | 4 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $10,000 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $174,000 | 19 | ABBVIE INC. ($79,000) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Tarsus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| 12/09/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $30,000.00 | General |
| 12/09/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 12/04/2024 | Glaukos Corporation | iDose (Device) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Glaucoma | ||||||
| 12/01/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 11/20/2024 | Tarsus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| 11/06/2024 | Glaukos Corporation | iDose (Device) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Glaucoma | ||||||
| 11/06/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 11/06/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/01/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 10/16/2024 | Glaukos Corporation | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 10/09/2024 | Tarsus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,400.00 | General |
| 10/09/2024 | Tarsus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| 10/08/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 09/25/2024 | Glaukos Corporation | iDose (Device) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Glaucoma | ||||||
| 09/11/2024 | Glaukos Corporation | iDose (Device) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Glaucoma | ||||||
| 06/25/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 05/15/2024 | Glaukos Corporation | iDose (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Glaucoma | ||||||
| 04/10/2024 | Glaukos Corporation | iDose (Device) | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| Category: Glaucoma | ||||||
About Dr. Wiley Chambers, M.D
Dr. Wiley Chambers, M.D is a Ophthalmology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770591711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wiley Chambers, M.D has received a total of $174,000 in payments from pharmaceutical and medical device companies, with $174,000 received in 2024. These payments were reported across 19 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($151,600).
Practice Information
- Specialty Ophthalmology
- Location Washington, DC
- Active Since 08/04/2006
- Last Updated 07/08/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770591711
Products in Payments
- iDose (Device) $57,600
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Washington
Keesha Williams-Elliott, M.d, M.D
Ophthalmology — Payments: $148,955
Dr. Dipak Panigrahi, Md, MD
Ophthalmology — Payments: $95,574
Dr. Michael Korenfeld, Md, MD
Ophthalmology — Payments: $78,793
Leslie Jones, Md, MD
Ophthalmology — Payments: $29,248
Samuel Stopak, M.d, M.D
Ophthalmology — Payments: $28,624
Richard North, Md, MD
Ophthalmology — Payments: $20,477